COMP <GO>
ICLR vs MEDP // RETURN ON INVESTED CAPITAL (ROIC)
ICON plc (NASDAQ) VS. Medpace Holdings Inc. (NASDAQ) • 15-METRIC TALLY: ICLR 4
— MEDP 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MEDP
LAST: $205.14 (-2.94%) • MKT CAP: $16.18B
roic
3.10%
LAST: $648.14 (-0.59%) • MKT CAP: $18.24B
roic
27.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICLR VS. MEDP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ICLR | MEDP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 3.10% | 27.90% | -24.80 | MEDP | /roic <GO> |
| EV/EBITDA & P/E Valuation | 31.7x | 34.0x | -2.30 | ICLR | /valuation <GO> |
| Free Cash Flow Yield | 5.22% | 3.60% | +1.62 | ICLR | /fcf-yield <GO> |
| Operating Margin | 5.40% | 21.10% | -15.70 | MEDP | /operating-margins <GO> |
| Net Profit Margin | 2.80% | 17.80% | -15.00 | MEDP | /net-margins <GO> |
| Revenue Growth (YoY) | 0.80% | 20.00% | -19.20 | MEDP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.20 | 9.13 | -6.93 | MEDP | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 70.6 | 52.4 | +18.20 | ICLR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.00 | +0.08 | ICLR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 66.9x | 35.3x | +31.60 | MEDP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.18B | $18.24B | -$2.05B | MEDP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ICLR REV | MEDP REV | ICLR GROSS % | MEDP GROSS % | ICLR FCF | MEDP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.25B | $2.53B | — | — | $862.0M | $681.9M |
| FY 2024 | $8.19B | $2.11B | 28.6% | — | $1.12B | $572.3M |
| FY 2023 | $8.05B | $1.89B | — | — | $798.6M | $348.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICLR // BETA 1.08
MEDP // BETA 1.00